Stakeholders ask FDA to harmonize oligonucleotide-based therapeutics guidances
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesBiotechnologyGenericsGuidancePharmaceuticalsRegulatory harmonizationRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)